Harmony Biosciences Holdings, Inc.
HRMY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802665
In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Harmony Biosciences Holdings, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 147
- +46 vs. Q3 2021
- Shares held
- 44.6M
- +13.6M (+44.1%) vs. Q3 2021
- Total value
- $1.90B
- +$714.5M (+60.3%) vs. Q3 2021
- New holders
- 60
- 40 more added
- Sold out
- 14
- 31 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HRMY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 328 | $1.97B |
| Q1 2026 | 311 | $1.57B |
| Q4 2025 | 325 | $1.87B |
| Q3 2025 | 296 | $1.31B |
| Q2 2025 | 279 | $1.62B |
| Q1 2025 | 272 | $1.67B |
| Q4 2024 | 247 | $1.82B |
| Q3 2024 | 234 | $2.01B |
| Q2 2024 | 219 | $1.51B |
| Q1 2024 | 207 | $1.64B |
| Q4 2023 | 221 | $1.54B |
| Q3 2023 | 205 | $1.62B |
| Q2 2023 | 211 | $1.83B |
| Q1 2023 | 218 | $1.68B |
| Q4 2022 | 242 | $2.81B |
| Q3 2022 | 203 | $2.24B |
| Q2 2022 | 184 | $2.34B |
| Q1 2022 | 182 | $2.26B |
| Q4 2021 | 147 | $1.90B |
| Q3 2021 | 102 | $1.19B |
| Q2 2021 | 84 | $790.3M |
| Q1 2021 | 57 | $907.6M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Harmony Biosciences Holdings, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 48,987 | $2.09M | 0.00% | +34,098+229.0% | Added |
| Polar Asset Management Partners Inc. | 51,600 | $2.20M | 0.03% | +51,600 | New |
| Legal & General Group Plc | 52,629 | $2.25M | 0.00% | +46,191+717.5% | Added |
| Voloridge Investment Management, LLC | 53,540 | $2.28M | 0.01% | +53,540 | New |
| Rhumbline Advisers | 53,589 | $2.29M | 0.00% | +33,492+166.7% | Added |
| SEI Investments Co | 57,894 | $2.47M | 0.00% | −5,824−9.1% | Reduced |
| CIBC Private Wealth Group, LLC | 60,000 | $2.56M | 0.01% | 00.0% | Unchanged |
| Wellington Management Group LLP | 60,694 | $2.59M | 0.00% | +60,694 | New |
| Citadel Advisors LLC | 90,431 | $3.86M | 0.00% | +49,384+120.3% | Added |
| Ameriprise Financial Inc | 94,433 | $4.03M | 0.00% | +94,433 | New |
| Invesco Ltd. | 110,361 | $4.71M | 0.00% | +100,902+1,066.7% | Added |
| First Trust Advisors LP | 114,625 | $4.89M | 0.00% | +114,625 | New |
| Bellevue Group AG | 121,161 | $5.17M | 0.05% | −8,128−6.3% | Reduced |
| Baker Bros. Advisors LP | 123,600 | $5.27M | 0.03% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 134,800 | $5.75M | 0.01% | +95,400+242.1% | Added |
| Rice Hall James & Associates, LLC | 137,646 | $5.87M | 0.21% | −1,568−1.1% | Reduced |
| MPM Oncology Impact Management LP | 142,437 | $6.07M | 1.11% | −9,213−6.1% | Reduced |
| Principal Financial Group Inc | 158,557 | $6.76M | 0.00% | +158,557 | New |
| Morgan Stanley | 171,107 | $7.30M | 0.00% | +126,623+284.6% | Added |
| HealthInvest Partners AB | 195,000 | $8.31M | 11.72% | +10,000+5.4% | Added |
| Dimensional Fund Advisors LP | 195,121 | $8.32M | 0.00% | +158,725+436.1% | Added |
| Bank of New York Mellon Corp | 199,411 | $8.50M | 0.00% | +130,858+190.9% | Added |
| Royce & Associates LP | 219,084 | $9.34M | 0.07% | −10,306−4.5% | Reduced |
| Rhenman & Partners Asset Management AB | 220,000 | $9.53M | 0.63% | +15,124+7.4% | Added |
| International Biotechnology Trust PLC | 236,000 | $10.1M | 2.24% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 239,258 | $10.2M | 0.16% | −252,074−51.3% | Reduced |
| Northern Trust Corp | 240,824 | $10.3M | 0.00% | +28,516+13.4% | Added |
| Charles Schwab Investment Management Inc | 267,049 | $11.4M | 0.00% | +35,020+15.1% | Added |
| Rothschild & Co Asset Management US Inc. | 282,034 | $12.0M | 0.14% | −17,985−6.0% | Reduced |
| Aisling Capital Management LP | 355,415 | $15.2M | 5.35% | −237,400−40.0% | Reduced |
| Nuveen Asset Management, LLC | 383,994 | $16.4M | 0.00% | −77,272−16.8% | Reduced |
| Geode Capital Management, LLC | 424,828 | $18.1M | 0.00% | +13,718+3.3% | Added |
| American Century Companies Inc | 475,824 | $20.3M | 0.01% | +287,013+152.0% | Added |
| Massachusetts Financial Services Co | 559,868 | $23.9M | 0.01% | −107,916−16.2% | Reduced |
| Ashford Capital Management Inc | 694,783 | $29.6M | 2.95% | +64,310+10.2% | Added |
| Nan Fung Group Holdings Ltd | 768,708 | $32.8M | 9.70% | 00.0% | Unchanged |
| State Street Corp | 775,683 | $33.1M | 0.00% | +378,825+95.5% | Added |
| Newlight Partners LP | 900,824 | $38.4M | 2.12% | −1,000,000−52.6% | Reduced |
| Blackstone Group Inc. | 1,048,951 | $44.7M | 0.11% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 1,543,724 | $65.8M | 0.03% | +324,165+26.6% | Added |
| Adage Capital Partners GP, L.L.C. | 1,750,000 | $74.6M | 0.13% | +509,585+41.1% | Added |
| Vanguard Group Inc | 2,659,085 | $113.4M | 0.00% | −440,856−14.2% | Reduced |
| venBio Partners LLC | 2,740,411 | $116.9M | 21.05% | −322,783−10.5% | Reduced |
| BlackRock Inc. | 3,739,766 | $159.5M | 0.00% | +2,125,593+131.7% | Added |
| FMR LLC | 4,207,599 | $179.4M | 0.01% | +78,648+1.9% | Added |
| Vivo Capital, LLC | 4,884,341 | $208.3M | 12.56% | 00.0% | Unchanged |
| Valor Management LLC | 11,218,033 | $478.3M | 76.20% | +11,218,033 | New |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −102,292−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Cambiar Investors LLC | 0 | $0 | 0.00% | −82,222−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Novo Holdings A/S | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −27,799−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −8,541−100.0% | Sold out |
| Cannon Global Investment Management, LLC | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −6,753−100.0% | Sold out |
| Zebra Capital Management LLC | 0 | $0 | 0.00% | −6,173−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Evolution Wealth Advisors, LLC | 0 | $0 | 0.00% | −107−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |